LumiraDx Limited (LMDXF)
OTCMKTS: LMDXF · Delayed Price · USD
0.0200
-0.0003 (-1.48%)
Apr 19, 2024, 4:00 PM EDT - Market closed

LumiraDx Market Cap

LumiraDx has a market cap or net worth of $6.38 million as of April 19, 2024. Its market cap has decreased by -97.72% in one year.

Market Cap
6.38M
Enterprise Value
383.79M
1-Year Change
-97.72%
Ranking
n/a
Category
Stock Price
$0.02

Market Cap Chart

Since January 27, 2021, LumiraDx's market cap has decreased from $127.00M to $6.38M, a decrease of -94.98%. That is a compound annual growth rate of -63.75%.

History

DateMarket Cap% Change
Jan 8, 20245.10M-52.78%
Jan 5, 202410.80M-12.90%
Jan 4, 202412.40M-9.49%
Jan 3, 202413.70M-12.18%
Jan 2, 202415.60M-22.39%
Dec 29, 202320.10M-1.47%
Dec 28, 202320.40M-5.99%
Dec 27, 202321.70M4.83%
Dec 26, 202320.70M-8.41%
Dec 22, 202322.60M-8.13%
Dec 21, 202324.60M-7.17%
Dec 20, 202326.50M-7.67%
Dec 19, 202328.70M-8.31%
Dec 18, 202331.30M-2.80%
Dec 15, 202332.20M-6.40%
Dec 14, 202334.40M-1.99%
Dec 13, 202335.10M-11.14%
Dec 12, 202339.50M27.83%
Dec 11, 202330.90M-1.28%
Dec 8, 202331.30M-2.80%
Dec 7, 202332.20M-8.26%
Dec 6, 202335.10M2.03%
Dec 5, 202334.40M-10.18%
Dec 4, 202338.30M2.68%
Dec 1, 202337.30M-31.93%
View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 709.22B
Novo Nordisk 556.82B
UnitedHealth Group 454.68B
Johnson & Johnson 351.20B
Merck & Co. 317.16B
AbbVie 291.56B
AstraZeneca 211.90B
Thermo Fisher 206.71B
Market Cap Rankings